Giulia Santagati
Overview
Explore the profile of Giulia Santagati including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
13
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Torreggiani M, Fois A, Santagati G, De Marco O, Bedogni S, Cacciatori N, et al.
Pediatr Nephrol
. 2024 Nov;
PMID: 39601824
Maternal undernutrition during pregnancy is associated with adverse effects in the offspring during adulthood and contributes to the risk of developing a number of chronic diseases. Historical events, such as...
2.
Chimenti G, Magli A, Spanu G, Santagati G, Fois A, Njandjo L, et al.
J Nephrol
. 2024 Sep;
37(7):1807-1812.
PMID: 39271638
Contraception, pregnancy and fertility are seldom discussed with women receiving dialysis and the medical staff of dialysis centres. Since the majority of women on dialysis are past childbearing age, these...
3.
Torreggiani M, Fois A, Samoreau C, Santagati G, Piccoli G
J Nephrol
. 2022 Nov;
35(9):2417-2423.
PMID: 36396845
Thrice weekly hemodialysis (HD) is considered the standard of care for patients with end-stage chronic kidney disease (CKD) on extracorporeal renal replacement therapy. However, recent evidence has shown that up...
4.
Torreggiani M, Fois A, Moio M, Chatrenet A, Maze B, Lippi F, et al.
Nutrients
. 2021 Dec;
13(12).
PMID: 34959922
The recent guidelines on nutritional management of chronic kidney disease (CKD) advise a reduction in protein intake as early as CKD stage 3, regardless of age, to slow kidney function...
5.
Piccoli G, Trabace T, Chatrenet A, Carranza de La Torre C, Gendrot L, Nielsen L, et al.
Int J Environ Res Public Health
. 2020 Feb;
17(4).
PMID: 32075103
Background: Dialysis treatment is improving, but several long-term problems remain unsolved, including metabolic bone disease linked to chronic kidney disease (CKD-MBD). The availability of new, efficacious but expensive drugs (intravenous...
6.
Santagati G, Cataldo E, Columbano V, Chatrenet A, Penna D, Pelosi E, et al.
J Clin Med
. 2019 Sep;
8(9).
PMID: 31546847
Background: The improvements in dialysis have not eliminated long-term problems, including dialysis-related amyloidosis (DRA), caused by Beta-2 microglobulin deposition. Several types of scintigraphy have been tested to detect DRA, none...
7.
Sofronie A, Kooij I, Bursot C, Santagati G, Coindre J, Piccoli G
BMC Nephrol
. 2018 May;
19(1):112.
PMID: 29751781
Background: Although the relationship between hyperparathyroidism and hypertension has been described for decades, the role of hyperparathyroidism in hypertension in dialysis is still unclear. Following the case of a severely...